Longping Yao1, Maryam Hatami1, Wenbin Ma2

  • 1Institute for Anatomy and Cell Biology, Heidelberg Medical Faculty, Heidelberg University, Heidelberg, Germany.

PubMed
概括

质瘤免疫疗法面临着挑战,特别是质母细胞瘤 (GBM). 瘤抗原向疫苗显示出有效的质瘤治疗的前景,特别是涉及CD4+T细胞.